Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Linking MLL and the HGF-MET signaling pathway in liver cancer
Jens U. Marquardt
, Snorri S. Thorgeirsson
*
*
Corresponding author for this work
Clinic of Internal Medicine I
National Cancer Institute
8
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Linking MLL and the HGF-MET signaling pathway in liver cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Liver Cancer
100%
Cell Signaling Pathway
100%
Hepatocyte Growth Factor
100%
Carcinoma Cell
50%
Hepatocellular Carcinoma
50%
Hematopoiesis
50%
Stem Cell Self-Renewal
50%
Chromosome Aberration
50%
Acute Leukemia
50%
Biochemistry, Genetics and Molecular Biology
Epigenetics
100%
Hepatocyte Growth Factor
100%
Myeloid
50%
Chromosomal Aberration
50%
Cell Cycle
50%
DNA Damage
50%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatocyte Growth Factor
100%
Liver Cancer
100%
Liver Cell Carcinoma
50%
Leukemia
50%
Chromosome Aberration
50%
Immunology and Microbiology
Lineage
50%
Myeloid
50%
Cell Cycle
50%